MedKoo Cat#: 413746 | Name: Obidoxime Br

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Obidoxime Br is a member of the oxime family used to treat nerve gas poisoning.

Chemical Structure

Obidoxime Br
Obidoxime Br
CAS#2337-82-8 (Br)

Theoretical Analysis

MedKoo Cat#: 413746

Name: Obidoxime Br

CAS#: 2337-82-8 (Br)

Chemical Formula: C14H16Br2N4O3

Exact Mass:

Molecular Weight: 448.12

Elemental Analysis: C, 37.52; H, 3.60; Br, 35.66; N, 12.50; O, 10.71

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Obidoxime Br; S100; S-100; S 100
IUPAC/Chemical Name
Pyridinium, 1,1'-(oxydimethylene)bis(4-formyl-, dibromide, dioxime
InChi Key
XPOPRXIULMKCGN-UHFFFAOYSA-N
InChi Code
InChI=1S/C14H14N4O3.2BrH/c19-15-9-13-1-5-17(6-2-13)11-21-12-18-7-3-14(4-8-18)10-16-20;;/h1-10H,11-12H2;2*1H
SMILES Code
O/N=C/C1=CC=[N+](COC[N+]2=CC=C(/C=N/O)C=C2)C=C1.[Br-].[Br-]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 448.12 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Muckova L, Pejchal J, Jost P, Vanova N, Herman D, Jun D. Cytotoxicity of acetylcholinesterase reactivators evaluated in vitro and its relation to their structure. Drug Chem Toxicol. 2019 May;42(3):252-256. doi: 10.1080/01480545.2018.1432641. Epub 2018 Feb 9. PMID: 29421945. 2: Inns RH, Leadbeater L. The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig. J Pharm Pharmacol. 1983 Jul;35(7):427-33. doi: 10.1111/j.2042-7158.1983.tb04316.x. PMID: 6136583. 3: Kassa J, Bajgar J. The influence of pharmacological pretreatment on efficacy of HI-6 oxime in combination with benactyzine in soman poisoning in rats. Hum Exp Toxicol. 1996 May;15(5):383-8. doi: 10.1177/096032719601500503. PMID: 8735460. 4: Hauser W, Kirsch D, Weger N. Therapeutic effects of new oximes, benactyzine and atropine in Soman poisoning: Part II. effect of HGG12, HGG42, and obidoxime in poisoning with various anticholinesterase agents in Beagle dogs. Fundam Appl Toxicol. 1981 Mar-Apr;1(2):164-8. doi: 10.1016/s0272-0590(81)80054-1. PMID: 6764202. 5: Cosar A, Kenar L. An anesthesiological approach to nerve agent victims. Mil Med. 2006 Jan;171(1):7-11. doi: 10.7205/milmed.171.1.7. PMID: 16532866. 6: Krejcová G, Kassa J. Neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in tabun-poisoned rats. Toxicology. 2003 Mar 14;185(1-2):129-39. doi: 10.1016/s0300-483x(02)00599-1. PMID: 12505451. 7: Grossmüller M, Antony J, Tränkle C, Holzgrabe U, Mohr K. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist. Naunyn Schmiedebergs Arch Pharmacol. 2006 Jan;372(4):267-76. doi: 10.1007/s00210-005-0023-4. Epub 2005 Dec 16. PMID: 16362429. 8: Sakurada K, Ikegaya H, Ohta H, Fukushima H, Akutsu T, Watanabe K. Effects of oximes on mitochondrial oxidase activity. Toxicol Lett. 2009 Sep 10;189(2):110-4. doi: 10.1016/j.toxlet.2009.05.007. Epub 2009 May 22. PMID: 19465093. 9: Kassa J, Vachek J. A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabun-poisoned rats and mice. Toxicology. 2002 Aug 15;177(2-3):179-85. doi: 10.1016/s0300-483x(02)00219-6. PMID: 12135621. 10: Jepsen K, Lüllmann H, Mohr K, Pfeffer J. Allosteric stabilization of 3H-N- methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication. Pharmacol Toxicol. 1988 Sep;63(3):163-8. doi: 10.1111/j.1600-0773.1988.tb00932.x. PMID: 3054859.